Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-010541
Filing Date
2025-12-19
Accepted
2025-12-19 16:05:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4764
  Complete submission text file 0001950047-25-010541.txt   6224
Mailing Address C/O SGX PHARMACEUTICALS, INC. 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
GREY MICHAEL G (Reporting) CIK: 0001240122 (see all company filings)

Type: 144

Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Subject) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38981 | Film No.: 251587541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)